In all, how insulin modulates IDE expression levels or activity in cancer cells in different models, with and without the microenvironment, and how IDE inhibition in cancer cells affects the insulin/IGF pathways and, consequently, tumor metabolism and survival, are key questions worth exploring. This evidence concerns the gene INS and neoplasm.